Medical Care
Global Peptide Manufacturing and Development Services Market Research Report 2025
- May 12, 25
- ID: 237239
- Pages: 89
- Figures: 83
- Views: 1
The global market for Peptide Manufacturing and Development Services was valued at US$ 2558 million in the year 2024 and is projected to reach a revised size of US$ 4435 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Peptide manufacturing and development services refer to specialized services provided by companies and organizations involved in the production and development of peptides, which are short chains of amino acids. These services cater to a wide range of industries, including pharmaceuticals, biotechnology, cosmetics, and research.
Peptide manufacturing and development services constitute a rapidly growing market within the biopharmaceutical sector. With the continuous advancement of global biotechnology and pharmaceutical research, peptides, as crucial components of therapeutic drugs, are experiencing a rising demand. The market size is expanding, and sales are consistently increasing. Providers of peptide manufacturing and development services offer pharmaceutical companies and research institutions high-quality, customized solutions for peptide synthesis and development, catering to diverse therapeutic areas. In the future, with ongoing innovations in biopharmaceutical technology, specific uses of peptides in fields such as oncology, immunomodulation, and neuroscience are expected to further expand, presenting significant development opportunities for the peptide manufacturing and development services market.
This report aims to provide a comprehensive presentation of the global market for Peptide Manufacturing and Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Manufacturing and Development Services.
The Peptide Manufacturing and Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Manufacturing and Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Manufacturing and Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
Segment by Type
GMP Services
Non-GMP Services
Segment by Application
Commercial Production
Scientific Research
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Manufacturing and Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Peptide manufacturing and development services refer to specialized services provided by companies and organizations involved in the production and development of peptides, which are short chains of amino acids. These services cater to a wide range of industries, including pharmaceuticals, biotechnology, cosmetics, and research.
Peptide manufacturing and development services constitute a rapidly growing market within the biopharmaceutical sector. With the continuous advancement of global biotechnology and pharmaceutical research, peptides, as crucial components of therapeutic drugs, are experiencing a rising demand. The market size is expanding, and sales are consistently increasing. Providers of peptide manufacturing and development services offer pharmaceutical companies and research institutions high-quality, customized solutions for peptide synthesis and development, catering to diverse therapeutic areas. In the future, with ongoing innovations in biopharmaceutical technology, specific uses of peptides in fields such as oncology, immunomodulation, and neuroscience are expected to further expand, presenting significant development opportunities for the peptide manufacturing and development services market.
This report aims to provide a comprehensive presentation of the global market for Peptide Manufacturing and Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Manufacturing and Development Services.
The Peptide Manufacturing and Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Manufacturing and Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Manufacturing and Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
Segment by Type
GMP Services
Non-GMP Services
Segment by Application
Commercial Production
Scientific Research
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Manufacturing and Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Manufacturing and Development Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 GMP Services
1.2.3 Non-GMP Services
1.3 Market by Application
1.3.1 Global Peptide Manufacturing and Development Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial Production
1.3.3 Scientific Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Manufacturing and Development Services Market Perspective (2020-2031)
2.2 Global Peptide Manufacturing and Development Services Growth Trends by Region
2.2.1 Global Peptide Manufacturing and Development Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide Manufacturing and Development Services Historic Market Size by Region (2020-2025)
2.2.3 Peptide Manufacturing and Development Services Forecasted Market Size by Region (2026-2031)
2.3 Peptide Manufacturing and Development Services Market Dynamics
2.3.1 Peptide Manufacturing and Development Services Industry Trends
2.3.2 Peptide Manufacturing and Development Services Market Drivers
2.3.3 Peptide Manufacturing and Development Services Market Challenges
2.3.4 Peptide Manufacturing and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Manufacturing and Development Services Players by Revenue
3.1.1 Global Top Peptide Manufacturing and Development Services Players by Revenue (2020-2025)
3.1.2 Global Peptide Manufacturing and Development Services Revenue Market Share by Players (2020-2025)
3.2 Global Peptide Manufacturing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide Manufacturing and Development Services Revenue
3.4 Global Peptide Manufacturing and Development Services Market Concentration Ratio
3.4.1 Global Peptide Manufacturing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Manufacturing and Development Services Revenue in 2024
3.5 Global Key Players of Peptide Manufacturing and Development Services Head office and Area Served
3.6 Global Key Players of Peptide Manufacturing and Development Services, Product and Application
3.7 Global Key Players of Peptide Manufacturing and Development Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Manufacturing and Development Services Breakdown Data by Type
4.1 Global Peptide Manufacturing and Development Services Historic Market Size by Type (2020-2025)
4.2 Global Peptide Manufacturing and Development Services Forecasted Market Size by Type (2026-2031)
5 Peptide Manufacturing and Development Services Breakdown Data by Application
5.1 Global Peptide Manufacturing and Development Services Historic Market Size by Application (2020-2025)
5.2 Global Peptide Manufacturing and Development Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide Manufacturing and Development Services Market Size (2020-2031)
6.2 North America Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide Manufacturing and Development Services Market Size by Country (2020-2025)
6.4 North America Peptide Manufacturing and Development Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Manufacturing and Development Services Market Size (2020-2031)
7.2 Europe Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide Manufacturing and Development Services Market Size by Country (2020-2025)
7.4 Europe Peptide Manufacturing and Development Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Manufacturing and Development Services Market Size (2020-2031)
8.2 Asia-Pacific Peptide Manufacturing and Development Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Manufacturing and Development Services Market Size (2020-2031)
9.2 Latin America Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide Manufacturing and Development Services Market Size by Country (2020-2025)
9.4 Latin America Peptide Manufacturing and Development Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Manufacturing and Development Services Market Size (2020-2031)
10.2 Middle East & Africa Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem Peptide Manufacturing and Development Services Introduction
11.1.4 Bachem Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Details
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide Peptide Manufacturing and Development Services Introduction
11.2.4 PolyPeptide Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.2.5 PolyPeptide Recent Development
11.3 CordenPharma
11.3.1 CordenPharma Company Details
11.3.2 CordenPharma Business Overview
11.3.3 CordenPharma Peptide Manufacturing and Development Services Introduction
11.3.4 CordenPharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.3.5 CordenPharma Recent Development
11.4 AmbioPharm
11.4.1 AmbioPharm Company Details
11.4.2 AmbioPharm Business Overview
11.4.3 AmbioPharm Peptide Manufacturing and Development Services Introduction
11.4.4 AmbioPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.4.5 AmbioPharm Recent Development
11.5 USV Peptides
11.5.1 USV Peptides Company Details
11.5.2 USV Peptides Business Overview
11.5.3 USV Peptides Peptide Manufacturing and Development Services Introduction
11.5.4 USV Peptides Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.5.5 USV Peptides Recent Development
11.6 Thermofischer
11.6.1 Thermofischer Company Details
11.6.2 Thermofischer Business Overview
11.6.3 Thermofischer Peptide Manufacturing and Development Services Introduction
11.6.4 Thermofischer Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.6.5 Thermofischer Recent Development
11.7 Bio Basic
11.7.1 Bio Basic Company Details
11.7.2 Bio Basic Business Overview
11.7.3 Bio Basic Peptide Manufacturing and Development Services Introduction
11.7.4 Bio Basic Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.7.5 Bio Basic Recent Development
11.8 JPT
11.8.1 JPT Company Details
11.8.2 JPT Business Overview
11.8.3 JPT Peptide Manufacturing and Development Services Introduction
11.8.4 JPT Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.8.5 JPT Recent Development
11.9 Genscript
11.9.1 Genscript Company Details
11.9.2 Genscript Business Overview
11.9.3 Genscript Peptide Manufacturing and Development Services Introduction
11.9.4 Genscript Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.9.5 Genscript Recent Development
11.10 Xinbang Pharma
11.10.1 Xinbang Pharma Company Details
11.10.2 Xinbang Pharma Business Overview
11.10.3 Xinbang Pharma Peptide Manufacturing and Development Services Introduction
11.10.4 Xinbang Pharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.10.5 Xinbang Pharma Recent Development
11.11 ScinoPharm
11.11.1 ScinoPharm Company Details
11.11.2 ScinoPharm Business Overview
11.11.3 ScinoPharm Peptide Manufacturing and Development Services Introduction
11.11.4 ScinoPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.11.5 ScinoPharm Recent Development
11.12 SN Biopharm
11.12.1 SN Biopharm Company Details
11.12.2 SN Biopharm Business Overview
11.12.3 SN Biopharm Peptide Manufacturing and Development Services Introduction
11.12.4 SN Biopharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.12.5 SN Biopharm Recent Development
11.13 CBL
11.13.1 CBL Company Details
11.13.2 CBL Business Overview
11.13.3 CBL Peptide Manufacturing and Development Services Introduction
11.13.4 CBL Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.13.5 CBL Recent Development
11.14 Piramal Pharma
11.14.1 Piramal Pharma Company Details
11.14.2 Piramal Pharma Business Overview
11.14.3 Piramal Pharma Peptide Manufacturing and Development Services Introduction
11.14.4 Piramal Pharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.14.5 Piramal Pharma Recent Development
11.15 CPC Scientific
11.15.1 CPC Scientific Company Details
11.15.2 CPC Scientific Business Overview
11.15.3 CPC Scientific Peptide Manufacturing and Development Services Introduction
11.15.4 CPC Scientific Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.15.5 CPC Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Manufacturing and Development Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 GMP Services
1.2.3 Non-GMP Services
1.3 Market by Application
1.3.1 Global Peptide Manufacturing and Development Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial Production
1.3.3 Scientific Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Manufacturing and Development Services Market Perspective (2020-2031)
2.2 Global Peptide Manufacturing and Development Services Growth Trends by Region
2.2.1 Global Peptide Manufacturing and Development Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide Manufacturing and Development Services Historic Market Size by Region (2020-2025)
2.2.3 Peptide Manufacturing and Development Services Forecasted Market Size by Region (2026-2031)
2.3 Peptide Manufacturing and Development Services Market Dynamics
2.3.1 Peptide Manufacturing and Development Services Industry Trends
2.3.2 Peptide Manufacturing and Development Services Market Drivers
2.3.3 Peptide Manufacturing and Development Services Market Challenges
2.3.4 Peptide Manufacturing and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Manufacturing and Development Services Players by Revenue
3.1.1 Global Top Peptide Manufacturing and Development Services Players by Revenue (2020-2025)
3.1.2 Global Peptide Manufacturing and Development Services Revenue Market Share by Players (2020-2025)
3.2 Global Peptide Manufacturing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide Manufacturing and Development Services Revenue
3.4 Global Peptide Manufacturing and Development Services Market Concentration Ratio
3.4.1 Global Peptide Manufacturing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Manufacturing and Development Services Revenue in 2024
3.5 Global Key Players of Peptide Manufacturing and Development Services Head office and Area Served
3.6 Global Key Players of Peptide Manufacturing and Development Services, Product and Application
3.7 Global Key Players of Peptide Manufacturing and Development Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Manufacturing and Development Services Breakdown Data by Type
4.1 Global Peptide Manufacturing and Development Services Historic Market Size by Type (2020-2025)
4.2 Global Peptide Manufacturing and Development Services Forecasted Market Size by Type (2026-2031)
5 Peptide Manufacturing and Development Services Breakdown Data by Application
5.1 Global Peptide Manufacturing and Development Services Historic Market Size by Application (2020-2025)
5.2 Global Peptide Manufacturing and Development Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide Manufacturing and Development Services Market Size (2020-2031)
6.2 North America Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide Manufacturing and Development Services Market Size by Country (2020-2025)
6.4 North America Peptide Manufacturing and Development Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Manufacturing and Development Services Market Size (2020-2031)
7.2 Europe Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide Manufacturing and Development Services Market Size by Country (2020-2025)
7.4 Europe Peptide Manufacturing and Development Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Manufacturing and Development Services Market Size (2020-2031)
8.2 Asia-Pacific Peptide Manufacturing and Development Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Manufacturing and Development Services Market Size (2020-2031)
9.2 Latin America Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide Manufacturing and Development Services Market Size by Country (2020-2025)
9.4 Latin America Peptide Manufacturing and Development Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Manufacturing and Development Services Market Size (2020-2031)
10.2 Middle East & Africa Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem Peptide Manufacturing and Development Services Introduction
11.1.4 Bachem Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Details
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide Peptide Manufacturing and Development Services Introduction
11.2.4 PolyPeptide Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.2.5 PolyPeptide Recent Development
11.3 CordenPharma
11.3.1 CordenPharma Company Details
11.3.2 CordenPharma Business Overview
11.3.3 CordenPharma Peptide Manufacturing and Development Services Introduction
11.3.4 CordenPharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.3.5 CordenPharma Recent Development
11.4 AmbioPharm
11.4.1 AmbioPharm Company Details
11.4.2 AmbioPharm Business Overview
11.4.3 AmbioPharm Peptide Manufacturing and Development Services Introduction
11.4.4 AmbioPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.4.5 AmbioPharm Recent Development
11.5 USV Peptides
11.5.1 USV Peptides Company Details
11.5.2 USV Peptides Business Overview
11.5.3 USV Peptides Peptide Manufacturing and Development Services Introduction
11.5.4 USV Peptides Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.5.5 USV Peptides Recent Development
11.6 Thermofischer
11.6.1 Thermofischer Company Details
11.6.2 Thermofischer Business Overview
11.6.3 Thermofischer Peptide Manufacturing and Development Services Introduction
11.6.4 Thermofischer Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.6.5 Thermofischer Recent Development
11.7 Bio Basic
11.7.1 Bio Basic Company Details
11.7.2 Bio Basic Business Overview
11.7.3 Bio Basic Peptide Manufacturing and Development Services Introduction
11.7.4 Bio Basic Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.7.5 Bio Basic Recent Development
11.8 JPT
11.8.1 JPT Company Details
11.8.2 JPT Business Overview
11.8.3 JPT Peptide Manufacturing and Development Services Introduction
11.8.4 JPT Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.8.5 JPT Recent Development
11.9 Genscript
11.9.1 Genscript Company Details
11.9.2 Genscript Business Overview
11.9.3 Genscript Peptide Manufacturing and Development Services Introduction
11.9.4 Genscript Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.9.5 Genscript Recent Development
11.10 Xinbang Pharma
11.10.1 Xinbang Pharma Company Details
11.10.2 Xinbang Pharma Business Overview
11.10.3 Xinbang Pharma Peptide Manufacturing and Development Services Introduction
11.10.4 Xinbang Pharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.10.5 Xinbang Pharma Recent Development
11.11 ScinoPharm
11.11.1 ScinoPharm Company Details
11.11.2 ScinoPharm Business Overview
11.11.3 ScinoPharm Peptide Manufacturing and Development Services Introduction
11.11.4 ScinoPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.11.5 ScinoPharm Recent Development
11.12 SN Biopharm
11.12.1 SN Biopharm Company Details
11.12.2 SN Biopharm Business Overview
11.12.3 SN Biopharm Peptide Manufacturing and Development Services Introduction
11.12.4 SN Biopharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.12.5 SN Biopharm Recent Development
11.13 CBL
11.13.1 CBL Company Details
11.13.2 CBL Business Overview
11.13.3 CBL Peptide Manufacturing and Development Services Introduction
11.13.4 CBL Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.13.5 CBL Recent Development
11.14 Piramal Pharma
11.14.1 Piramal Pharma Company Details
11.14.2 Piramal Pharma Business Overview
11.14.3 Piramal Pharma Peptide Manufacturing and Development Services Introduction
11.14.4 Piramal Pharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.14.5 Piramal Pharma Recent Development
11.15 CPC Scientific
11.15.1 CPC Scientific Company Details
11.15.2 CPC Scientific Business Overview
11.15.3 CPC Scientific Peptide Manufacturing and Development Services Introduction
11.15.4 CPC Scientific Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.15.5 CPC Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Peptide Manufacturing and Development Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of GMP Services
Table 3. Key Players of Non-GMP Services
Table 4. Global Peptide Manufacturing and Development Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Peptide Manufacturing and Development Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Peptide Manufacturing and Development Services Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Peptide Manufacturing and Development Services Market Share by Region (2020-2025)
Table 8. Global Peptide Manufacturing and Development Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Peptide Manufacturing and Development Services Market Share by Region (2026-2031)
Table 10. Peptide Manufacturing and Development Services Market Trends
Table 11. Peptide Manufacturing and Development Services Market Drivers
Table 12. Peptide Manufacturing and Development Services Market Challenges
Table 13. Peptide Manufacturing and Development Services Market Restraints
Table 14. Global Peptide Manufacturing and Development Services Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Peptide Manufacturing and Development Services Market Share by Players (2020-2025)
Table 16. Global Top Peptide Manufacturing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Manufacturing and Development Services as of 2024)
Table 17. Ranking of Global Top Peptide Manufacturing and Development Services Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Peptide Manufacturing and Development Services Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Peptide Manufacturing and Development Services, Headquarters and Area Served
Table 20. Global Key Players of Peptide Manufacturing and Development Services, Product and Application
Table 21. Global Key Players of Peptide Manufacturing and Development Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peptide Manufacturing and Development Services Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Peptide Manufacturing and Development Services Revenue Market Share by Type (2020-2025)
Table 25. Global Peptide Manufacturing and Development Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Peptide Manufacturing and Development Services Revenue Market Share by Type (2026-2031)
Table 27. Global Peptide Manufacturing and Development Services Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Peptide Manufacturing and Development Services Revenue Market Share by Application (2020-2025)
Table 29. Global Peptide Manufacturing and Development Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Peptide Manufacturing and Development Services Revenue Market Share by Application (2026-2031)
Table 31. North America Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Peptide Manufacturing and Development Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bachem Company Details
Table 47. Bachem Business Overview
Table 48. Bachem Peptide Manufacturing and Development Services Product
Table 49. Bachem Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 50. Bachem Recent Development
Table 51. PolyPeptide Company Details
Table 52. PolyPeptide Business Overview
Table 53. PolyPeptide Peptide Manufacturing and Development Services Product
Table 54. PolyPeptide Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 55. PolyPeptide Recent Development
Table 56. CordenPharma Company Details
Table 57. CordenPharma Business Overview
Table 58. CordenPharma Peptide Manufacturing and Development Services Product
Table 59. CordenPharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 60. CordenPharma Recent Development
Table 61. AmbioPharm Company Details
Table 62. AmbioPharm Business Overview
Table 63. AmbioPharm Peptide Manufacturing and Development Services Product
Table 64. AmbioPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 65. AmbioPharm Recent Development
Table 66. USV Peptides Company Details
Table 67. USV Peptides Business Overview
Table 68. USV Peptides Peptide Manufacturing and Development Services Product
Table 69. USV Peptides Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 70. USV Peptides Recent Development
Table 71. Thermofischer Company Details
Table 72. Thermofischer Business Overview
Table 73. Thermofischer Peptide Manufacturing and Development Services Product
Table 74. Thermofischer Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 75. Thermofischer Recent Development
Table 76. Bio Basic Company Details
Table 77. Bio Basic Business Overview
Table 78. Bio Basic Peptide Manufacturing and Development Services Product
Table 79. Bio Basic Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 80. Bio Basic Recent Development
Table 81. JPT Company Details
Table 82. JPT Business Overview
Table 83. JPT Peptide Manufacturing and Development Services Product
Table 84. JPT Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 85. JPT Recent Development
Table 86. Genscript Company Details
Table 87. Genscript Business Overview
Table 88. Genscript Peptide Manufacturing and Development Services Product
Table 89. Genscript Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 90. Genscript Recent Development
Table 91. Xinbang Pharma Company Details
Table 92. Xinbang Pharma Business Overview
Table 93. Xinbang Pharma Peptide Manufacturing and Development Services Product
Table 94. Xinbang Pharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 95. Xinbang Pharma Recent Development
Table 96. ScinoPharm Company Details
Table 97. ScinoPharm Business Overview
Table 98. ScinoPharm Peptide Manufacturing and Development Services Product
Table 99. ScinoPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 100. ScinoPharm Recent Development
Table 101. SN Biopharm Company Details
Table 102. SN Biopharm Business Overview
Table 103. SN Biopharm Peptide Manufacturing and Development Services Product
Table 104. SN Biopharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 105. SN Biopharm Recent Development
Table 106. CBL Company Details
Table 107. CBL Business Overview
Table 108. CBL Peptide Manufacturing and Development Services Product
Table 109. CBL Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 110. CBL Recent Development
Table 111. Piramal Pharma Company Details
Table 112. Piramal Pharma Business Overview
Table 113. Piramal Pharma Peptide Manufacturing and Development Services Product
Table 114. Piramal Pharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 115. Piramal Pharma Recent Development
Table 116. CPC Scientific Company Details
Table 117. CPC Scientific Business Overview
Table 118. CPC Scientific Peptide Manufacturing and Development Services Product
Table 119. CPC Scientific Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 120. CPC Scientific Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Peptide Manufacturing and Development Services Picture
Figure 2. Global Peptide Manufacturing and Development Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide Manufacturing and Development Services Market Share by Type: 2024 VS 2031
Figure 4. GMP Services Features
Figure 5. Non-GMP Services Features
Figure 6. Global Peptide Manufacturing and Development Services Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Peptide Manufacturing and Development Services Market Share by Application: 2024 VS 2031
Figure 8. Commercial Production Case Studies
Figure 9. Scientific Research Case Studies
Figure 10. Other Case Studies
Figure 11. Peptide Manufacturing and Development Services Report Years Considered
Figure 12. Global Peptide Manufacturing and Development Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Peptide Manufacturing and Development Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Peptide Manufacturing and Development Services Market Share by Region: 2024 VS 2031
Figure 15. Global Peptide Manufacturing and Development Services Market Share by Players in 2024
Figure 16. Global Top Peptide Manufacturing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Manufacturing and Development Services as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Peptide Manufacturing and Development Services Revenue in 2024
Figure 18. North America Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Peptide Manufacturing and Development Services Market Share by Country (2020-2031)
Figure 20. United States Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Peptide Manufacturing and Development Services Market Share by Country (2020-2031)
Figure 24. Germany Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Peptide Manufacturing and Development Services Market Share by Region (2020-2031)
Figure 32. China Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Peptide Manufacturing and Development Services Market Share by Country (2020-2031)
Figure 40. Mexico Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Peptide Manufacturing and Development Services Market Share by Country (2020-2031)
Figure 44. Turkey Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bachem Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 48. PolyPeptide Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 49. CordenPharma Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 50. AmbioPharm Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 51. USV Peptides Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 52. Thermofischer Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 53. Bio Basic Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 54. JPT Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 55. Genscript Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 56. Xinbang Pharma Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 57. ScinoPharm Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 58. SN Biopharm Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 59. CBL Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 60. Piramal Pharma Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 61. CPC Scientific Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Peptide Manufacturing and Development Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of GMP Services
Table 3. Key Players of Non-GMP Services
Table 4. Global Peptide Manufacturing and Development Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Peptide Manufacturing and Development Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Peptide Manufacturing and Development Services Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Peptide Manufacturing and Development Services Market Share by Region (2020-2025)
Table 8. Global Peptide Manufacturing and Development Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Peptide Manufacturing and Development Services Market Share by Region (2026-2031)
Table 10. Peptide Manufacturing and Development Services Market Trends
Table 11. Peptide Manufacturing and Development Services Market Drivers
Table 12. Peptide Manufacturing and Development Services Market Challenges
Table 13. Peptide Manufacturing and Development Services Market Restraints
Table 14. Global Peptide Manufacturing and Development Services Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Peptide Manufacturing and Development Services Market Share by Players (2020-2025)
Table 16. Global Top Peptide Manufacturing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Manufacturing and Development Services as of 2024)
Table 17. Ranking of Global Top Peptide Manufacturing and Development Services Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Peptide Manufacturing and Development Services Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Peptide Manufacturing and Development Services, Headquarters and Area Served
Table 20. Global Key Players of Peptide Manufacturing and Development Services, Product and Application
Table 21. Global Key Players of Peptide Manufacturing and Development Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peptide Manufacturing and Development Services Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Peptide Manufacturing and Development Services Revenue Market Share by Type (2020-2025)
Table 25. Global Peptide Manufacturing and Development Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Peptide Manufacturing and Development Services Revenue Market Share by Type (2026-2031)
Table 27. Global Peptide Manufacturing and Development Services Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Peptide Manufacturing and Development Services Revenue Market Share by Application (2020-2025)
Table 29. Global Peptide Manufacturing and Development Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Peptide Manufacturing and Development Services Revenue Market Share by Application (2026-2031)
Table 31. North America Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Peptide Manufacturing and Development Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bachem Company Details
Table 47. Bachem Business Overview
Table 48. Bachem Peptide Manufacturing and Development Services Product
Table 49. Bachem Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 50. Bachem Recent Development
Table 51. PolyPeptide Company Details
Table 52. PolyPeptide Business Overview
Table 53. PolyPeptide Peptide Manufacturing and Development Services Product
Table 54. PolyPeptide Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 55. PolyPeptide Recent Development
Table 56. CordenPharma Company Details
Table 57. CordenPharma Business Overview
Table 58. CordenPharma Peptide Manufacturing and Development Services Product
Table 59. CordenPharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 60. CordenPharma Recent Development
Table 61. AmbioPharm Company Details
Table 62. AmbioPharm Business Overview
Table 63. AmbioPharm Peptide Manufacturing and Development Services Product
Table 64. AmbioPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 65. AmbioPharm Recent Development
Table 66. USV Peptides Company Details
Table 67. USV Peptides Business Overview
Table 68. USV Peptides Peptide Manufacturing and Development Services Product
Table 69. USV Peptides Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 70. USV Peptides Recent Development
Table 71. Thermofischer Company Details
Table 72. Thermofischer Business Overview
Table 73. Thermofischer Peptide Manufacturing and Development Services Product
Table 74. Thermofischer Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 75. Thermofischer Recent Development
Table 76. Bio Basic Company Details
Table 77. Bio Basic Business Overview
Table 78. Bio Basic Peptide Manufacturing and Development Services Product
Table 79. Bio Basic Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 80. Bio Basic Recent Development
Table 81. JPT Company Details
Table 82. JPT Business Overview
Table 83. JPT Peptide Manufacturing and Development Services Product
Table 84. JPT Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 85. JPT Recent Development
Table 86. Genscript Company Details
Table 87. Genscript Business Overview
Table 88. Genscript Peptide Manufacturing and Development Services Product
Table 89. Genscript Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 90. Genscript Recent Development
Table 91. Xinbang Pharma Company Details
Table 92. Xinbang Pharma Business Overview
Table 93. Xinbang Pharma Peptide Manufacturing and Development Services Product
Table 94. Xinbang Pharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 95. Xinbang Pharma Recent Development
Table 96. ScinoPharm Company Details
Table 97. ScinoPharm Business Overview
Table 98. ScinoPharm Peptide Manufacturing and Development Services Product
Table 99. ScinoPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 100. ScinoPharm Recent Development
Table 101. SN Biopharm Company Details
Table 102. SN Biopharm Business Overview
Table 103. SN Biopharm Peptide Manufacturing and Development Services Product
Table 104. SN Biopharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 105. SN Biopharm Recent Development
Table 106. CBL Company Details
Table 107. CBL Business Overview
Table 108. CBL Peptide Manufacturing and Development Services Product
Table 109. CBL Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 110. CBL Recent Development
Table 111. Piramal Pharma Company Details
Table 112. Piramal Pharma Business Overview
Table 113. Piramal Pharma Peptide Manufacturing and Development Services Product
Table 114. Piramal Pharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 115. Piramal Pharma Recent Development
Table 116. CPC Scientific Company Details
Table 117. CPC Scientific Business Overview
Table 118. CPC Scientific Peptide Manufacturing and Development Services Product
Table 119. CPC Scientific Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
Table 120. CPC Scientific Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Peptide Manufacturing and Development Services Picture
Figure 2. Global Peptide Manufacturing and Development Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide Manufacturing and Development Services Market Share by Type: 2024 VS 2031
Figure 4. GMP Services Features
Figure 5. Non-GMP Services Features
Figure 6. Global Peptide Manufacturing and Development Services Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Peptide Manufacturing and Development Services Market Share by Application: 2024 VS 2031
Figure 8. Commercial Production Case Studies
Figure 9. Scientific Research Case Studies
Figure 10. Other Case Studies
Figure 11. Peptide Manufacturing and Development Services Report Years Considered
Figure 12. Global Peptide Manufacturing and Development Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Peptide Manufacturing and Development Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Peptide Manufacturing and Development Services Market Share by Region: 2024 VS 2031
Figure 15. Global Peptide Manufacturing and Development Services Market Share by Players in 2024
Figure 16. Global Top Peptide Manufacturing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Manufacturing and Development Services as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Peptide Manufacturing and Development Services Revenue in 2024
Figure 18. North America Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Peptide Manufacturing and Development Services Market Share by Country (2020-2031)
Figure 20. United States Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Peptide Manufacturing and Development Services Market Share by Country (2020-2031)
Figure 24. Germany Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Peptide Manufacturing and Development Services Market Share by Region (2020-2031)
Figure 32. China Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Peptide Manufacturing and Development Services Market Share by Country (2020-2031)
Figure 40. Mexico Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Peptide Manufacturing and Development Services Market Share by Country (2020-2031)
Figure 44. Turkey Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bachem Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 48. PolyPeptide Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 49. CordenPharma Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 50. AmbioPharm Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 51. USV Peptides Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 52. Thermofischer Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 53. Bio Basic Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 54. JPT Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 55. Genscript Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 56. Xinbang Pharma Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 57. ScinoPharm Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 58. SN Biopharm Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 59. CBL Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 60. Piramal Pharma Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 61. CPC Scientific Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Krypton Flash Lamp Market Research Report 2025
May 12, 25
Global IR Halogen Lamp Market Research Report 2025
May 12, 25
Global Halogen IR Lamp Market Research Report 2025
May 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232